MRIKi-67:

Peyman Tabnak1, Zanyar HajiEsmailPoor1, Behzad Baradaran2

  • 1Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran (P.T., Z.H.); Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran (P.T., Z.H., B.B., L.A.M.); Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran (P.T., Z.H., B.B., L.A.M.).

Academic radiology
|November 4, 2023
PubMed
概括

基于MRI的放射学在预测乳腺癌中的Ki-67表达方面表现出很好的准确性,但低于90%的灵敏度和特异性限制了其作为唯一的病理评估工具的使用.